SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Papi Alberto)
 

Sökning: WFRF:(Papi Alberto) > Relationship of Inh...

Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma

Papi, Alberto (författare)
University of Ferrara
Ryan, Dermot (författare)
University of Edinburgh,Optimum Patient Care Ltd
Soriano, Joan B. (författare)
Autonomous University of Barcelona
visa fler...
Chrystyn, Henry (författare)
Observational and Pragmatic Research Institute Pte Ltd,Inhalation Consultancy Ltd
Bjermer, Leif (författare)
Lund University,Lunds universitet,Lungmedicin, allergologi och palliativ medicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Respiratory Medicine, Allergology, and Palliative Medicine,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine
Rodríguez-Roisin, Roberto (författare)
University of Barcelona
Dolovich, Myrna B. (författare)
McMaster University
Harris, Mark (författare)
Optimum Patient Care Ltd
Wood, Lucy (författare)
Observational and Pragmatic Research Institute Pte Ltd
Batsiou, Maria (författare)
Observational and Pragmatic Research Institute Pte Ltd
Thornhill, Susannah I. (författare)
Observational and Pragmatic Research Institute Pte Ltd
Price, David B. (författare)
Observational and Pragmatic Research Institute Pte Ltd,University of Aberdeen
visa färre...
 (creator_code:org_t)
Elsevier BV, 2018
2018
Engelska.
Ingår i: Journal of Allergy and Clinical Immunology: In Practice. - : Elsevier BV. - 2213-2198. ; 6:6, s. 3-1998
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Patients with asthma and elevated blood eosinophils are at increased risk of severe exacerbations. Management of these patients should consider nonadherence to inhaled corticosteroid (ICS) therapy as a factor for increased exacerbation risk. Objective: The objective of this study was to investigate whether poor adherence to ICS therapy explains the occurrence of asthma exacerbations in patients with elevated blood eosinophil levels. Methods: This historical cohort study identified patients within the Optimum Patient Care Research Database, aged 18 years or more, at Global Initiative for Asthma step 3 or 4, with 2 or more ICS prescriptions during the year before the clinical review. Patient characteristics and adherence (based on prescription refills and patient self-report) for ICS therapy were analyzed for those with elevated (>400 cells/μL) or normal (≤400 cells/μL) blood eosinophils. Results: We studied 7195 patients (66% female, mean age 60 years) with median eosinophil count of 200 cells/μL and found 81% to be not fully adherent to ICS therapy. A total of 1031 patients (14%) had elevated blood eosinophil counts (58% female, mean age 60 years), 83% of whom were not fully adherent to ICS. An increased proportion of adherent patients in the elevated blood eosinophil group had 2 or more exacerbations (14.0% vs 7.2%; P =.003) and uncontrolled asthma (73% vs 60.8%; P =.004) as compared with non–fully adherent patients. Conclusions: Approximately 1 in 7 patients had elevated eosinophils. Adherence to ICS therapy was not associated with decreased exacerbations for these patients. Additional therapy should be considered for these patients, such as biologics, which have been previously shown to improve control in severe uncontrolled eosinophilic asthma.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)

Nyckelord

Adherence
Asthma control
Asthma exacerbations
Eosinophils
Inhaled corticosteroids
Severe asthma

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy